Search research articles
Contact Us
Filters
Showing results (71-80 of 81) with videos related to
Page
of 9
Sort By:
The Journal of Neuroscience : the Official Journal of the Society for Neuroscience
|
October 22, 2002
Therapeutic effects of cystamine in a murine model of Huntington's disease
Alpaslan Dedeoglu, James K Kubilus, Thomas M Jeitner, et al.
Human Molecular Genetics
|
April 4, 2007
Modulation of nucleosome dynamics in Huntington's disease
Edward C Stack, Steven J Del Signore, Ruth Luthi-Carter, et al.
The Journal of Biological Chemistry
|
October 7, 2005
Mitochondrial cyclic AMP response element-binding protein (CREB) mediates mitochondrial gene expression and neuronal survival
Junghee Lee, Chun-Hyung Kim, David K Simon, et al.
The Journal of Neuroscience : the Official Journal of the Society for Neuroscience
|
November 23, 2007
Neuroprotective effects of synaptic modulation in Huntington's disease R6/2 mice
Edward C Stack, Alpaslan Dedeoglu, Karen M Smith, et al.
Nature
|
May 3, 2002
Minocycline inhibits cytochrome c release and delays progression of amyotrophic lateral sclerosis in mice
Shan Zhu, Irina G Stavrovskaya, Martin Drozda, et al.
The Journal of Neuroscience : the Official Journal of the Society for Neuroscience
|
November 19, 2004
Chemotherapy for the brain: the antitumor antibiotic mithramycin prolongs survival in a mouse model of Huntington's disease
Robert J Ferrante, Hoon Ryu, James K Kubilus, et al.
Journal of Neuroimmunology
|
May 12, 2005
Transcriptional therapy with the histone deacetylase inhibitor trichostatin A ameliorates experimental autoimmune encephalomyelitis
Sandra Camelo, Antonio H Iglesias, Daehee Hwang, et al.
Plos Biology
|
June 25, 2014
The Wnt receptor Ryk reduces neuronal and cell survival capacity by repressing FOXO activity during the early phases of mutant huntingtin pathogenicity
Cendrine Tourette, Francesca Farina, Rafael P Vazquez-Manrique, et al.
Movement Disorders : Official Journal of the Movement Disorder Society
|
July 30, 2010
Safety and tolerability of high-dosage coenzyme Q10 in Huntington's disease and healthy subjects
, H Christopher Hyson, Karl Kieburtz, et al.
Human Molecular Genetics
|
May 24, 2007
Mutant huntingtin's effects on striatal gene expression in mice recapitulate changes observed in human Huntington's disease brain and do not differ with mutant huntingtin length or wild-type huntingtin dosage
Alexandre Kuhn, Darlene R Goldstein, Angela Hodges, et al.
Page
of 9
Search research articles
Search
Showing results (71-80 of 81) with videos related to
Sort By:
Page
of 9
The Journal of Neuroscience : the Official Journal of the Society for Neuroscience
|
October 22, 2002
Therapeutic effects of cystamine in a murine model of Huntington's disease
Alpaslan Dedeoglu, James K Kubilus, Thomas M Jeitner, et al.
Human Molecular Genetics
|
April 4, 2007
Modulation of nucleosome dynamics in Huntington's disease
Edward C Stack, Steven J Del Signore, Ruth Luthi-Carter, et al.
The Journal of Biological Chemistry
|
October 7, 2005
Mitochondrial cyclic AMP response element-binding protein (CREB) mediates mitochondrial gene expression and neuronal survival
Junghee Lee, Chun-Hyung Kim, David K Simon, et al.
The Journal of Neuroscience : the Official Journal of the Society for Neuroscience
|
November 23, 2007
Neuroprotective effects of synaptic modulation in Huntington's disease R6/2 mice
Edward C Stack, Alpaslan Dedeoglu, Karen M Smith, et al.
Nature
|
May 3, 2002
Minocycline inhibits cytochrome c release and delays progression of amyotrophic lateral sclerosis in mice
Shan Zhu, Irina G Stavrovskaya, Martin Drozda, et al.
The Journal of Neuroscience : the Official Journal of the Society for Neuroscience
|
November 19, 2004
Chemotherapy for the brain: the antitumor antibiotic mithramycin prolongs survival in a mouse model of Huntington's disease
Robert J Ferrante, Hoon Ryu, James K Kubilus, et al.
Journal of Neuroimmunology
|
May 12, 2005
Transcriptional therapy with the histone deacetylase inhibitor trichostatin A ameliorates experimental autoimmune encephalomyelitis
Sandra Camelo, Antonio H Iglesias, Daehee Hwang, et al.
Plos Biology
|
June 25, 2014
The Wnt receptor Ryk reduces neuronal and cell survival capacity by repressing FOXO activity during the early phases of mutant huntingtin pathogenicity
Cendrine Tourette, Francesca Farina, Rafael P Vazquez-Manrique, et al.
Movement Disorders : Official Journal of the Movement Disorder Society
|
July 30, 2010
Safety and tolerability of high-dosage coenzyme Q10 in Huntington's disease and healthy subjects
, H Christopher Hyson, Karl Kieburtz, et al.
Human Molecular Genetics
|
May 24, 2007
Mutant huntingtin's effects on striatal gene expression in mice recapitulate changes observed in human Huntington's disease brain and do not differ with mutant huntingtin length or wild-type huntingtin dosage
Alexandre Kuhn, Darlene R Goldstein, Angela Hodges, et al.
Page
of 9